Skip to content

13F-HR filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-14, with 54 holding rows worth $338,813,000.

Accession
0001697013-19-000006
Filed
2019-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 54 entries on the cover page, a total value of $338,813,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $338,813,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AMARIN CORP PLC023111206SPONS ADR NEW2,060,287$42,772,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR803,185$34,065,000thousands by filing date
R1 RCM INC749397105COM2,963,659$28,659,000thousands by filing date
ZOGENIX INC.98978L204Common Stock495,429$27,254,000thousands by filing date
Danaher Corporation235851102COM158,764$20,985,000thousands by filing date
NUVASIVE INC670704105COM330,601$18,775,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR332,402$14,719,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW645,417$12,870,000thousands by filing date
EHEALTH INC28238P109COM200,649$12,508,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR103,296$12,158,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM83,574$9,961,000thousands by filing date
ENSIGN GROUP INC29358P101COM159,545$8,174,000thousands by filing date
ABIOMED INC003654100COM27,339$7,808,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM38,229$7,032,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM350,011$6,150,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock748,594$6,019,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM250,432$5,813,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM114,779$5,452,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock214,112$5,220,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR39,334$4,910,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM100,600$3,787,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW75,721$3,395,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock412,876$3,361,000thousands by filing date
ARQULE INC04269E107COM646,918$3,099,000thousands by filing date
TELIGENT INC NEW87960W104COM2,574,883$2,987,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK195,701$2,648,000thousands by filing date
DERMIRA INC24983L104COM179,500$2,432,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock224,340$2,279,000thousands by filing date
MEDICINES CO584688105COM76,200$2,130,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM104,349$2,035,000thousands by filing date
TRICIDA INC89610F101COM49,508$1,912,000thousands by filing date
MYOKARDIA INC62857M105COM35,052$1,822,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM120,036$1,637,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock42,400$1,515,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM107,296$1,425,000thousands by filing date
AFFIMED N VN01045108COM322,171$1,353,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock23,600$1,253,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS294,660$1,105,000thousands by filing date
CARETRUST REIT INC COM14174T107REIT41,264$977,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM69,708$975,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P908COM438$800,000thousands by filing date
INVACARE CORP461203101COMMON STOCK79,081$662,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM41,074$602,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK18,029$581,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM47,154$569,000thousands by filing date
HESKA CORP42805E306COM6,680$569,000thousands by filing date
OTONOMY INC68906L105COM180,100$474,000thousands by filing date
PFENEX INC717071104COM75,700$468,000thousands by filing date
BIOSCRIP INC09069N108COM123,011$246,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM73,717$199,000thousands by filing date
ILLUMINA INC452327109COM405$126,000thousands by filing date
NOVAVAX INC CMN STOCK670002954Cmn1,451$77,000thousands by filing date
CELGENE CORP151020112RIGHT 12/31/20306,000$7,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022905CALL23$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-19-000006this filing2019-05-14acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000011 base2023-11-08acceptance time not in the bulk data set